7 drug(s) with this reaction
2,224 total reports
Covid 19 has been reported as an adverse reaction across 7 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,224 adverse event reports mention covid 19 in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with covid 19, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have covid 19 listed in their FDA adverse event reports, sorted by report count:
In addition to covid 19, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
7 drug(s) manufactured by Chattem Inc have covid 19 listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, MENTHOL, CAMPHOR, MENTHOL, and others.
There are a combined 2,224 reports of covid 19 across 7 Chattem Inc drug(s) in the FDA adverse event database.